Ceva announces Q3 adjusted EPS of 11 cents, surpassing consensus of 10 cents
Q3 Financial Performance: Ceva reported Q3 revenue of $28.4M, surpassing the consensus estimate of $28.04M, with a non-GAAP gross margin of 89%, up from 87% in the previous year.
Strategic Licensing Agreements: The company secured several strategic licensing agreements, including a significant portfolio license for its NeuPro NPU family with Microchip, enhancing its position in wireless connectivity and AI expansion.
Growth in AI and Wireless IoT: Ceva's AI processor licensing is contributing significantly to its revenue, and wireless IoT shipments are at record highs, positioning the company for sustainable growth.
Focus on Physical AI: Ceva aims to lead in enabling Physical AI at the edge, reinforcing its role as a foundational technology provider for intelligent, connected devices.
Trade with 70% Backtested Accuracy
Analyst Views on CEVA
About CEVA
About the author

Apogee Therapeutics (APGE) Options Volume Surges 46.6% Today
- Active Options Trading: Apogee Therapeutics has seen an options volume of 4,166 contracts today, equating to approximately 416,600 shares, indicating a trading activity level of 46.6% of its average daily volume over the past month.
- High Demand Options: Notably, the $90 strike call option expiring on March 20, 2026, has seen a significant volume of 2,505 contracts traded today, representing about 250,500 shares, reflecting strong market interest at this strike price.
- Ceva Inc Options Activity: Concurrently, Ceva Inc has recorded an options volume of 1,294 contracts today, approximately 129,400 shares, which corresponds to 45.8% of its average daily trading volume over the past month.
- Increased Interest in Strike Price: Among Ceva's options, the $30 strike call option expiring on February 20, 2026, has seen a trading volume of 506 contracts today, representing around 50,600 shares, indicating a rising market focus on this strike price.

Ceva, Inc. to Announce Q4 and Full Year 2025 Results on February 17, 2026
- Earnings Announcement Schedule: Ceva, Inc. will release its Q4 and full year 2025 results on February 17, 2026, before the NASDAQ market opens, providing investors with critical operational performance data to analyze future growth trends.
- Conference Call Details: Following the earnings release, Ceva's management will hold a conference call at 8:30 a.m. Eastern Time to discuss quarterly performance, allowing investors to engage through designated dial-in numbers or a live webcast link, enhancing transparency and interaction.
- Replay Service: For investors unable to attend the live call, Ceva offers a replay service available from one hour after the call ends until 9:00 a.m. on March 17, 2026, ensuring all investors can access important information.
- Company Background: Ceva focuses on smart edge technology, having shipped over 20 billion devices to more than 400 customers globally, with its AI-driven product portfolio providing foundational technology for 5G, IoT, and autonomous driving, showcasing strong market competitiveness.






